AC Immune SA ACIU

Full chart Compare
Set alert

Price alert · ACIU

All alert types
2.13 USD +0.06 (+3.16%)

Nov 3, 2026, 3:21 PM EST

2.06 Day range 2.16
2.02 52-week range 3.90
YTD
-32.32%
1 year
-33.18%

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 10.01 +370.9% upside
Target (low)
7.54
Target (mean)
10.01
Target (high)
15.77
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 4
  • 2 months ago 4
  • 3 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ACIU analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.187-0.201 – -0.17-0.05-274.0%556.43K-96.2%3
Next quarter0.000.00 – 0.00-0.180.0%00.0%0
Current year-0.536-0.552 – -0.52-0.64+16.3%26.79M+81.0%2
Next year-0.03033-0.75 – 0.359-0.536+94.3%61.61M+130.0%3

Upgrades and downgrades

The latest rating changes

ACIU analyst upgrades and downgrades
DateFirmActionFromTo
Nov 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 6, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 18, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 31, 2024BTIGInitiated—Buy
Mar 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 13, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 7, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 28, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 1, 2023HC Wainwright & Co.Reiterated—Buy
Apr 19, 2023HC Wainwright & Co.Reiterated—Buy
Mar 17, 2023HC Wainwright & Co.Reiterated—Buy
Jul 11, 2022SVB LeerinkMaintained—Outperform
Dec 20, 2021SVB LeerinkMaintained—Outperform
Mar 24, 2021HC Wainwright & Co.Maintained—Buy
Dec 10, 2019HC Wainwright & Co.Reiterated—Buy
Feb 1, 2019UBSDowngradeBuyNeutral
Nov 13, 2018Leerink SwannInitiated—Outperform
Apr 5, 2018HC Wainwright & Co.Initiated—Buy
Oct 18, 2016Leerink SwannInitiated—Outperform